Table 2 Characteristics of prostate cancer patients
Variables | N = 470 |
|---|---|
n (%) | |
Mean age ± SD | 67.8 ± 7.6 |
Missing (%): | 2.3 |
Mean BMI ± SD | 28.1 ± 4.5 |
Missing (%) | 3.8 |
Working status | |
Active | 83 (17.7) |
Sick leave | 15 (3.1) |
Retired | 347 (73.8) |
Unemployed | 17 (3.6) |
Other | 4 (0.9) |
Missing | 4 (0.9) |
Education (%) | |
No education | 47 (10.2) |
Incomplete primary education | 80 (17.2) |
Primary education | 109 (23.5) |
Graduate school | 99 (21.3) |
Upper secondary studies | 62 (13.4) |
University | 67 (14.5) |
Missing | 6 (1.2) |
Setting first consultation (%) | |
Primary care | 355 (75.5) |
Hospital | 86 (18.5) |
Other | 23 (5.0) |
Missing | 6 (1.2) |
Symptoms (%) | |
No symptoms or discomfort | 251 (53.4) |
One or more symptoms | 170 (36.2) |
Missing | 49 (10.4) |
Start of first symptoms including patients with discomfort (%) | |
Since one month | 55 (11.7) |
Between one month and one year | 242 (51.4) |
Later than a year | 56 (12.0) |
No symptoms | 68 (14.5) |
Missing | 49 (10.4) |
ECOG WHO (%) | |
Fully active: | 356 (75.7) |
Restricted or worse: | 105 (22.3) |
Missing: | 9 (2.0) |
Charlson index (%) | |
1: | 358 (75.8) |
2: | 68 (14.4) |
3: | 26 (5.5) |
4: | 13 (2.8) |
≥5: | 5 (1.5) |
Median PSA (ng/mL) ± IQR | 7.6 ± 7.8 |
Missing (%): | 3.4 |
Total Gleason (%) | |
2-6: | 262 (55.6) |
7: | 127 (26.9) |
>7: | 74 (15.6) |
Missing: | 7 (1.9) |
Median total Gleason ± IQR | 6.0 ± 1.0 |
Primary tumour clinical stage (T) (%) | |
Tx: | 1 (0.2) |
T1a-c | 194 (41.0) |
T2a-c: | 189 (40.1) |
T3a-b : | 74 (15.7) |
T4: | 8 (1.7) |
Missing: | 4 (1.3) |
Regional lymph nodes clinical stage (N) (%) | |
Nx-N0: | 460 (97.7) |
N1: | 10 (2.3) |
Missing: | 0 (0.0) |
Distance metastasis clinical stage (M) (%) | |
Mx-M0: | 460 (97.9) |
M1a-c: | 10 (2.1) |
Missing: | 0 (0.0) |
D’Amico Classification (%) | |
Low risk: | 170 (36.1) |
Medium risk: | 115 (24.5) |
High risk: | 185 (39.4) |
Missing: | 0 (0.0) |
Median time between first consultation and diagnosis in days ± IQR | 89.0 ± 123.5 |
Missing (%): | 4.0 |
Median time between diagnosis and first treatment in days ± IQR | 75.0 ± 78.0 |
Missing (%): | 3.2 |
Median time between first consultation and first treatment in days ± IQR | 176.0 ± 151.0 |
Missing (%): | 6.6 |